Menveo Warnings and Precautions

If you have HIV, diabetes, or any other immune-suppressing condition, tell your healthcare provider before receiving the Menveo vaccine. Other warnings and precautions include making sure your healthcare provider is aware of all medications you are taking. People who have a history of Guillain-Barré syndrome should not receive Menveo, nor should anyone who has had a serious reaction to a meningococcal vaccine before.

What Should I Tell My Healthcare Provider?

Before you receive Menveo® (meningococcal vaccine), tell your healthcare provider if you have:
 
  • Had any sort of a reaction to any vaccine in the past
  • A moderate or severe illness
  • Guillain-Barré syndrome
  • An immune-suppressing condition such as HIV or AIDS, diabetes, or cancer
  • A bleeding disorder
  • Any allergies, including to foods, dyes, or preservatives.
     
Also, let your healthcare provider know if you are:
 
  • Pregnant or thinking of becoming pregnant
  • Breastfeeding.
     
Make sure to tell your healthcare provider about any medications you are taking, including prescription and nonprescription medicines, vitamins, and herbal supplements.
 

Specific Precautions and Warnings With Menveo

Warnings and precautions to be aware of prior to receiving Menveo include the following:
 
  • Make sure your healthcare provider knows if you have ever had any serious reactions to any vaccines in the past. Depending on the particular vaccine and the severity of your reaction, your healthcare provider may decide not to give Menveo to you.
     
  • You can receive Menveo if you have a mild illness, such as the common cold. However, it is usually best to postpone the vaccine in the case of a moderate or severe illness.
     
  • If you have an immune-suppressing condition, this product may not be as effective as usual for protection against invasive meningococcal disease, as your immune system may not be fully capable of responding to it.
     
  • Although Menveo contains diphtheria toxoid, this vaccine does not provide protection against diphtheria. The diphtheria toxoid proteins are used to make this vaccine more effective.
     
  • A different meningococcal vaccine that is similar to Menveo may increase the risk of Guillain-Barré syndrome, a serious nerve disorder. It is unknown if Menveo also increases this risk.
     
  • Special precautions must be taken when giving intramuscular injections to people with bleeding disorders or who are taking anticoagulants (commonly known as "blood thinners").
     
  • Menveo is considered a pregnancy Category B medication. This means that it is probably safe for use during pregnancy, although the full risks are currently unknown (see Menveo and Pregnancy).
     
  • As with most vaccines, Menveo is generally considered safe for breastfeeding women (see Menveo and Breastfeeding).
     
  • Menveo does not contain thimerosal (a mercury-containing preservative). People who are concerned about exposure to this substance can be confident that this vaccine has no thimerosal -- not even trace amounts.
Some people also are concerned about the aluminum content of vaccines. This product contains no aluminum or other adjuvants (an adjuvant is an ingredient that does not induce any immune response by itself but increases the immune response of other components of the vaccine).
  • Menveo is not made from animal components or human fetal cell lines, unlike some vaccines.
     
7 Easy Tips for Starting Solids

Menveo Vaccine Information

Referring Pages:
Terms of Use
Advertise with Us
Contact Us
About eMedTV
Privacy Policy
Copyright © 2006-2017 Clinaero, Inc.
eMedTV serves only as an informational resource. This site does not dispense medical advice or advice of any kind. Site users seeking medical advice about their specific situation should consult with their own physician. Click Terms of Use for more information.